Senthil Sundaram - May 31, 2022 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Executive Officer, Director
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Senthil Sundaram
Stock symbol
TERN
Transactions as of
May 31, 2022
Transactions value $
$11,254
Form type
4
Date filed
6/8/2022, 09:27 PM
Previous filing
Jan 28, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $11.3K +7.66K $1.47* 7.66K May 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes the purchase of 7,656 shares under the Terns Employee Stock Purchase Plan on May 31, 2022.

Remarks:

Voluntary reporting of ESPP purchase